Patent · US Active

Flow and volume regulated inhalation for treatment of severe oral corticosteroid-dependent asthma

US8834848B2 · kind B2 · utility

8Cited by

7References

21Claims

0Family size

Assignee

Activaero GmbH Research & Development · DE

Inventors

Bernard Muellinger · Munich, DE
Gerhard Scheuch · Kirchberg, DE
Thomas Hofmann · Doylestown, US
Philipp Kroneberg · Olching, DE

Key dates

Filing date	Sep 6, 2012
Grant date	Sep 16, 2014
Priority date	—
Expiry date	Sep 6, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2205/502
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A drug and device combination system used in a method for treatment of patients suffering from severe and oral corticosteroid-dependent asthma and other respiratory diseases requiring a treatment with orally administered steroids. The method for administration of the inhalable corticosteroid by a flow rate and volume regulated inhalation. The combination system of the inhalable corticosteroid and the device for regulating flow rate and volume of the inhalable corticosteroid and thus achieving delivery of said inhalable corticosteroid into the small airways of the lungs. The individually programmable device that assures safe and reproducible corticosteroid delivery compliant with treatment protocol.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.